Shares of USANA Health Sciences, Inc. (NYSE:USNA – Get Free Report) hit a new 52-week low on Wednesday . The stock traded as low as $30.16 and last traded at $30.32, with a volume of 5576 shares. The stock had previously closed at $30.97.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on the company. StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 28th. DA Davidson boosted their target price on shares of USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research report on Thursday, January 2nd.
Read Our Latest Report on USNA
USANA Health Sciences Stock Performance
Hedge Funds Weigh In On USANA Health Sciences
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Barclays PLC increased its position in USANA Health Sciences by 111.9% during the third quarter. Barclays PLC now owns 27,737 shares of the company’s stock worth $1,052,000 after acquiring an additional 14,647 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in USANA Health Sciences by 14,068.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock valued at $1,472,000 after acquiring an additional 38,547 shares in the last quarter. Assenagon Asset Management S.A. raised its holdings in USANA Health Sciences by 13.5% in the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock valued at $4,702,000 after acquiring an additional 14,756 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of USANA Health Sciences by 4.5% in the 3rd quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock worth $11,269,000 after acquiring an additional 12,898 shares during the period. Finally, State Street Corp grew its holdings in shares of USANA Health Sciences by 0.6% during the 3rd quarter. State Street Corp now owns 435,164 shares of the company’s stock worth $16,501,000 after purchasing an additional 2,782 shares in the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Recommended Stories
- Five stocks we like better than USANA Health Sciences
- Election Stocks: How Elections Affect the Stock Market
- Inflation Persists, But So Do Stock Opportunities: Rally On
- How to Short Nasdaq: An Easy-to-Follow Guide
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
- Profitably Trade Stocks at 52-Week Highs
- Shopify Confirms Stock Uptrend, New Highs in Sight
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.